Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis

Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis

Abstract Introduction In STRIVE, natalizumab treatment demonstrated effectiveness in clinical, magnetic resonance imaging (MRI), and patient-reported outcomes (PROs) in patients with early relapsing–remitting multiple sclerosis (RRMS). This post hoc analysis examined the effectiveness and safety of...

Full description

Bibliographic Details
Main Authors: Jai Perumal, Roumen Balabanov, Laura Balcer, Steven Galetta, Zhaonan Sun, Hanyue Li, Danette Rutledge, Robin L. Avila, Robert J. Fox
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-03-01
Series:Neurology and Therapy
Subjects:
African American
Cognitive processing speed
Hispanic
Natalizumab
No evidence of disease activity
Patient-reported outcome
Online Access:https://doi.org/10.1007/s40120-023-00461-0

Internet

https://doi.org/10.1007/s40120-023-00461-0

Similar Items